OWA
EBS icon

One Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

One Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
16,636
-43
-0.3% -$360 0.02% 321
2026
Q1 		$138K Buy
+16,679
New +$173K 0.02% 297
2019
Q2 		– Sell
-1,521
Closed -$77K – 216
2019
Q1 		$77K Buy
+1,521
New +$89.7K 0.06% 202
2018
Q4 		– Sell
-1,944
Closed -$128K – 208
2018
Q3 		$128K Sell
1,944
-50
-3% -$2.92K 0.1% 164
2018
Q2 		$101K Sell
1,994
-60
-3% -$3.13K 0.08% 189
2018
Q1 		$108K Sell
2,054
-107
-5% -$5.33K 0.1% 165
2017
Q4 		$100K Buy
+2,161
New +$91K 0.08% 196

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

One Wealth Advisors's EBS Position: Q2 2026 in Review

One Wealth Advisors reduced its Emergent Biosolutions (EBS) stake by 0.26% in Q2 2026, selling an estimated $360 and leaving 16,636 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #321.

One Wealth Advisors first reported a position in EBS in Q4 2017 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • One Wealth Advisors held 16,636 shares of Emergent Biosolutions worth $139K as of Q2 2026.
  • One Wealth Advisors sold 43 Emergent Biosolutions shares in Q2 2026, an estimated $360.
  • Emergent Biosolutions made up 0.02% of One Wealth Advisors's portfolio in Q2 2026, its #321 holding.
  • One Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.